Vertex Pharmaceuticals Incorporated Pharmaceutical preparations

Stock predictor AI models:
$ 294.45 Last close price
at 10-jul-2020

VRTX

Model's trade recommendations No return for period yet

$38.09B Market Cap

β 1.44  

VRTX

Model (following trade recommendations)

VRTX

Underlying stock

S&P 500

Index
Return for period
9.64%
1.78%
52wk return
67.50%
16.82%
52wk Range
166.23—299.06
2000.54—2399.63
  • STRONG BUY Analysts consensus recommendation

Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.

Industry sector: Medical

Sector classification: Pharmaceutical preparations

Float 250M
P/E 124.56
Shares Outstanding 255M
% Held by Insiders 1.80%
% Held by Institutions 94.80%
EPS (last reported FY) $0.80
EPS (last reported Q) $0.54
EPS, estimated (last reported Q) $0.28
Total revenues $2 B
Net income $0 B